Advances in Psychiatry II
January 30, 2021 @ 9:00 am - 12:15 pm PST
Registration for this meeting is now closed.
ONLINE: Saturday, January 30, 2021
9:00 A.M. – 12:15 P.M.
Schedule
9:00 A.M. – 10:30 A.M.
Paradise Lost
Charles B. Nemeroff, M.D., Ph.D
Matthew P. Nemeroff Endowed Chair, Department of Psychiatry & Behavioral Sciences; Director, Institute for Early Life Adversity Research; Professor, Department of Psychiatry & Behavioral Sciences, Dell Medical School, University of Texas at Austin
Dr. Nemeroff will discuss how genetic polymorphisms and epigenetics effect psychiatric disease vulnerability. This talk will also explain how a gene variation effects brain development and function so that the risk of a depressive episode or PTSD is increased. Dr. Nemeroff will explore and describe how early life experience produces persistent CNS alterations and its implications.
(Dr. Nemeroff reports the following Disclosures – Consultant/Advisory: Bracket Pharmaceuticals, Intracellular Therapies, Janssen, Magstim,Other Navitor, Sumitomo, Sunovion Pharmaceuticals Inc., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceuticals, Xhale; Grant/Research: Other NIH, Stanley Medical Research Institute; Stock: AbbVie Pharmaceutical, Celgene Corporation, Concept Therapeutics, Inc., Other Seattle Genetics, OPKO Health, Antares, BI Gen Holdings, Xhale)
10:45 A.M. – 12:15 P.M.
Coping with Covid-19: Technology Matters
Peter Yellowlees, M.D.
Professor of Psychiatry and Chief Wellness Officer at UC Davis Health
Dr. Yellowlees will review the impacts of the Covid-19 pandemic on mental health, and describe current telepsychiatry practices, including legal and regulatory changes, and how Covid-19 has led to a dramatically increased use of telepsychiatry, which he will describe as being good for the well-being of Psychiatrists and other mental health providers. He will conclude with thoughts on the silver-linings associated with the pandemic, and will discuss the long term trends for the use of telemedicine and other health IT technologies.
(Dr. Yellowlees reports that neither he nor his spouse/partner has any financial relationship with a commercial interest.)
3 Hours Category 1 CME will be provided
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Psychiatric Association (APA) and the Southern California Psychiatric Society. The APA is accredited by the ACCME to provide continuing medical education for physicians. The APA designates this activity for a maximum of 3 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Cancellations must be received 72 hours prior to the meeting and will be assessed a $15 administrative processing fee.
SCPS would like to thank: Michael Gales, M.D. (Program Chair), Patrick Kelly, M.D., and Samuel Miles, M.D. for planning this event.